Dacenon, Mary Jane C.

HRN: 26-78-85  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2025
CEFTRIAXONE 1G (VIAL)
07/10/2025
07/17/2025
IV
2G
Od
Urosepsis Sec To Complicated Uti
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary Tract    Compliance to guidelines: